ALPS Advisors’s Forte Biosciences FBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-682
| Closed | -$50K | – | 922 |
|
|
2021
Q3 | $50K | Sell |
682
-30
| -4% | -$2.2K | ﹤0.01% | 906 |
|
|
2021
Q2 | $598K | Buy |
+712
| New | +$598K | 0.01% | 496 |
|
|
2019
Q2 | – | Sell |
-148
| Closed | -$603K | – | 886 |
|
|
2019
Q1 | $603K | Buy |
148
+25
| +20% | +$102K | ﹤0.01% | 454 |
|
|
2018
Q4 | $379K | Buy |
123
+29
| +31% | +$89.4K | ﹤0.01% | 648 |
|
|
2018
Q3 | $550K | Buy |
94
+17
| +22% | +$99.5K | ﹤0.01% | 542 |
|
|
2018
Q2 | $270K | Buy |
77
+6
| +8% | +$21K | ﹤0.01% | 885 |
|
|
2018
Q1 | $315K | Buy |
71
+12
| +20% | +$53.2K | ﹤0.01% | 812 |
|
|
2017
Q4 | $225K | Buy |
59
+7
| +13% | +$26.7K | ﹤0.01% | 798 |
|
|
2017
Q3 | $243K | Buy |
52
+4
| +8% | +$18.7K | ﹤0.01% | 743 |
|
|
2017
Q2 | $215K | Buy |
+48
| New | +$215K | ﹤0.01% | 747 |
|